Arcturus Therapeutics Holdings Inc.
ARCT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,448 | -$9,180 | -$14,076 | -$30,005 |
| Dep. & Amort. | $763 | $779 | $801 | $819 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,729 | $6,200 | $6,662 | $8,983 |
| Change in WC | $3,666 | -$5,857 | -$28,546 | $20,091 |
| Other Non-Cash | -$13,861 | $2,303 | $21 | -$172 |
| Operating Cash Flow | -$17,151 | -$5,755 | -$35,138 | -$284 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$181 | $0 | -$137 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$181 | $0 | -$137 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $15,000 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,225 | -$14,726 | $195 | $134 |
| Financing Cash Flow | $1,225 | -$14,726 | $15,195 | $134 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$16,107 | -$20,481 | -$20,080 | -$150 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $253,352 | $273,833 | $293,913 | $294,063 |
| End Cash | $237,245 | $253,352 | $273,833 | $293,913 |
| Free Cash Flow | -$17,332 | -$5,755 | -$35,275 | -$284 |